Overall, our strategy, combining in silico and in vitro datasets, defined a set of 3 highly relevant candidate genes in the context of MTC: SEC23A, MAT2B, KIAA1191 (Figure 3). The gene discussed is KIAA1191; the disease is medullary thyroid gland carcinoma.